| Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosis T Fleischer, A Frigessi, KC Johnson, H Edvardsen, N Touleimat, J Klajic, ... Genome biology 15, 1-13, 2014 | 203 | 2014 |
| Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes B Győrffy, G Bottai, T Fleischer, G Munkácsy, J Budczies, L Paladini, ... International journal of cancer 138 (1), 87-97, 2016 | 149 | 2016 |
| Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer JA Rønneberg, T Fleischer, HK Solvang, SH Nordgard, H Edvardsen, ... Molecular oncology 5 (1), 61-76, 2011 | 143 | 2011 |
| DNA methylation at enhancers identifies distinct breast cancer lineages T Fleischer, X Tekpli, A Mathelier, S Wang, D Nebdal, HP Dhakal, ... Nature Communications 8 (1), 1379, 2017 | 114 | 2017 |
| Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors MR Aure, SK Leivonen, T Fleischer, Q Zhu, J Overgaard, J Alsner, ... Genome biology 14, 1-20, 2013 | 110 | 2013 |
| Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors J Klajic, T Fleischer, E Dejeux, H Edvardsen, F Warnberg, I Bukholm, ... BMC cancer 13, 1-12, 2013 | 87 | 2013 |
| Genome-wide DNA methylation analyses in lung adenocarcinomas: association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis MM Bjaanæs, T Fleischer, AR Halvorsen, A Daunay, F Busato, S Solberg, ... Molecular oncology 10 (2), 330-343, 2016 | 80 | 2016 |
| DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer KC Johnson, DC Koestler, T Fleischer, P Chen, EG Jenson, JD Marotti, ... Clinical epigenetics 7, 1-12, 2015 | 65 | 2015 |
| DNA Methylation Status of Key Cell-Cycle Regulators Such as CDKNA2/p16 and CCNA1 Correlates with Treatment Response to Doxorubicin and 5-Fluorouracil … J Klajic, F Busato, H Edvardsen, N Touleimat, T Fleischer, I Bukholm, ... Clinical cancer research 20 (24), 6357-6366, 2014 | 64 | 2014 |
| Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation AB Brinkman, S Nik-Zainal, F Simmer, FG Rodríguez-González, M Smid, ... Nature communications 10 (1), 1749, 2019 | 62 | 2019 |
| EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgery Å Helland, HM Skaug, L Kleinberg, ML Iversen, AK Rud, T Fleischer, ... Journal of Thoracic Oncology 6 (5), 947-950, 2011 | 55 | 2011 |
| Integrated analysis of high‐resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients T Fleischer, H Edvardsen, HK Solvang, C Daviaud, B Naume, ... International journal of cancer 134 (11), 2615-2625, 2014 | 51 | 2014 |
| The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors DA Quigley, E Fiorito, S Nord, P Van Loo, GG Alnæs, T Fleischer, J Tost, ... Molecular oncology 8 (2), 273-284, 2014 | 45 | 2014 |
| A multi‐omic study reveals BTG2 as a reliable prognostic marker for early‐stage non‐small cell lung cancer S Shen, R Zhang, Y Guo, E Loehrer, Y Wei, Y Zhu, Q Yuan, S Moran, ... Molecular oncology 12 (6), 913-924, 2018 | 36 | 2018 |
| Differential DNA methylation analysis of breast cancer reveals the impact of immune signaling in radiation therapy AR Halvorsen, Å Helland, T Fleischer, KM Haug, GI Grenaker Alnæs, ... International journal of cancer 135 (9), 2085-2095, 2014 | 36 | 2014 |
| The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer L Silwal-Pandit, S Nord, H von der Lippe Gythfeldt, EK Møller, T Fleischer, ... Clinical Cancer Research 23 (16), 4662-4670, 2017 | 35 | 2017 |
| Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer MR Aure, T Fleischer, S Bjørklund, J Ankill, JA Castro-Mondragon, ... Genome medicine 13 (1), 72, 2021 | 34 | 2021 |
| EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC R Zhang, L Lai, J He, C Chen, D You, W Duan, X Dong, Y Zhu, L Lin, ... Epigenetics 14 (2), 118-129, 2019 | 30 | 2019 |
| Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab S Jabeen, M Zucknick, M Nome, R Dannenfelser, T Fleischer, S Kumar, ... Oncoimmunology 7 (11), e1457598, 2018 | 29 | 2018 |
| Independent validation of early-stage non-small cell lung cancer prognostic scores incorporating epigenetic and transcriptional biomarkers with gene-gene interactions and main … R Zhang, C Chen, X Dong, S Shen, L Lai, J He, D You, L Lin, Y Zhu, ... Chest 158 (2), 808-819, 2020 | 28 | 2020 |
